Search by Drug Name or NDC

    NDC 16714-0892-01 Daptomycin 50 mg/mL Details

    Daptomycin 50 mg/mL

    Daptomycin is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar RxLLC. The primary component is DAPTOMYCIN.

    Product Information

    NDC 16714-0892
    Product ID 16714-892_1c9a367e-6213-3309-3883-e18ba367d57e
    Associated GPIs 16270030002140
    GCN Sequence Number 053190
    GCN Sequence Number Description daptomycin VIAL 500 MG INTRAVEN
    HIC3 W9B
    HIC3 Description CYCLIC LIPOPEPTIDES
    GCN 20569
    HICL Sequence Number 025673
    HICL Sequence Number Description DAPTOMYCIN
    Brand/Generic Generic
    Proprietary Name Daptomycin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Daptomycin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name DAPTOMYCIN
    Labeler Name NorthStar RxLLC
    Pharmaceutical Class Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208375
    Listing Certified Through 2024-12-31

    Package

    NDC 16714-0892-01 (16714089201)

    NDC Package Code 16714-892-01
    Billing NDC 16714089201
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-892-01) / 15 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2022-06-13
    NDC Exclude Flag N
    Pricing Information N/A